Accessibility Menu
 
BioAtla logo

BioAtla

(NASDAQ) BCAB

Current Price$0.13
Market Cap$9.68M
Since IPO (2020)-100%
5 Year-100%
1 Year-62%
1 Month-30%

BioAtla Financials at a Glance

Market Cap

$9.68M

Revenue (TTM)

$2.00M

Net Income (TTM)

$59.61M

EPS (TTM)

$-1.02

P/E Ratio

-0.13

Dividend

$0.00

Beta (Volatility)

1.74 (High)

Price

$0.13

Volume

7,573

Open

$0.13

Previous Close

$0.13

Daily Range

$0.13 - $0.14

52-Week Range

$0.12 - $1.43

BCAB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioAtla

Industry

Biotechnology

Employees

41

CEO

Jay M. Short, PhD

Headquarters

San Diego, CA 92121, US

BCAB Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-30%

Net Income Margin

-30%

Return on Equity

-814%

Return on Capital

7%

Return on Assets

-4%

Earnings Yield

-7.69%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.68M

Shares Outstanding

74.26M

Volume

7.57K

Short Interest

0.00%

Avg. Volume

2.30M

Financials (TTM)

Gross Profit

$2.00M

Operating Income

$59.30M

EBITDA

$58.93M

Operating Cash Flow

$48.20M

Capital Expenditure

$0.00

Free Cash Flow

$48.20M

Cash & ST Invst.

$7.12M

Total Debt

$6.20M

BioAtla Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$2.00M

N/A

Gross Profit

$2.81M

+124.1%

Gross Margin

1.40%

N/A

Market Cap

$9.68M

N/A

Market Cap/Employee

$158.75K

N/A

Employees

61

N/A

Net Income

$9.78M

+34.3%

EBITDA

$7.62M

+52.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$918.00K

-98.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$4.77M

N/A

Short Term Debt

$1.43M

+70.7%

Return on Assets

-4.31%

N/A

Return on Invested Capital

7.33%

N/A

Free Cash Flow

$7.92M

+52.8%

Operating Cash Flow

$7.92M

+52.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RVPHReviva Pharmaceuticals Holdings, Inc.
$0.72-11.08%
EVAXEvaxion Biotech A/S
$3.78-4.06%
BTAIBioXcel Therapeutics, Inc.
$1.18-3.28%
CELUCelularity Inc.
$1.33+1.53%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
NOKNokia
$8.82+0.07%

Questions About BCAB

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.